Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2021-08-02 2021-07-30
Drug Identification Number 02327848 02327848
Brand name NEUROLITE NEUROLITE
Common or Proper name Kit for the Preparation of Technetium Tc99m Bicisate for Injection Kit for the Preparation of Technetium Tc99m Bicisate for Injection
Company Name LANTHEUS MI CANADA INC LANTHEUS MI CANADA INC
Ingredients BICISATE DIHYDROCHLORIDE BICISATE DIHYDROCHLORIDE
Strength(s) 0.9MG 0.9MG
Dosage form(s) POWDER FOR SOLUTION KIT POWDER FOR SOLUTION KIT
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size Kits of 2 and kits of 5 vials Kits of 2 and kits of 5 vials
ATC code V09A V09A
ATC description
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an active ingredient.
Anticipated start date 2021-08-01 2021-08-01
Actual start date
Estimated end date 2021-08-31 2021-08-31
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments